Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products

Supply Chain Coordination Ltd (SCCL)

This public procurement record has 4 releases in its history.

Award

03 Dec 2025 at 22:28

Award Notice
Tender

04 Mar 2025 at 14:30

Tender Notice
TenderUpdate

04 Mar 2025 at 14:30

Tender Notice
Planning

07 Nov 2024 at 13:35

Planning Notice
Summary of the contracting process

The procurement process managed by NHS Supply Chain Coordination Ltd aims to establish a Framework Agreement for the supply of medical consumables, including insulin pumps, continuous glucose monitoring devices, and products contributing to hybrid closed-loop pathways. The process is conducted via an open procedure and is in the award stage as of December 2025, with contracts signed in November 2025. The framework agreement, valued between £960 million and £1,067 million excluding VAT over four years, covers various locations across the UK. This procurement is driven by the NICE Technology Appraisal, with key items classified under CPV code 33140000. Initially planned in November 2024, the procurement method includes electronic submissions. NHS Supply Chain, operating as the buyer, coordinates purchases primarily for NHS entities, government departments, and private sector entities in the UK healthcare sector.

This tender presents substantial growth opportunities for providers of medical consumables and technology solutions, particularly small and medium-sized enterprises specialising in healthcare technology innovations. With initial spending estimated at £240 million to £267 million GBP in the first year, rising in subsequent years, suppliers can leverage this substantial market demand. The focus on quality criteria, such as patient experience and customer support, along with social value, provides a strategic avenue for suppliers to enhance their offerings and compete effectively. Companies that align with sustainability, possess relevant certifications, and demonstrate strong commitment to social value stand well-positioned to benefit from this evolving demand, paving the way for considerable business expansion within the healthcare industry. Businesses such as Advanced Therapeutics (UK) Ltd and Air Liquide Healthcare Ltd are among the active suppliers, showcasing a diverse supplier ecosystem conducive to innovation and collaboration.

How relevant is this notice?

Notice Information

Notice Title

Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products

Notice Description

NHS Supply Chain seeks to establish a Framework Agreement for the supply of Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products. This includes but not limited to tethered and patch insulin pumps, continuous glucose monitoring devices, products that contribute to the functionality of hybrid closed loop insulin delivery systems, and consumables. Precise quantities are unknown. It is anticipated in the first year that spend will be approximately PS 240,000,000 - PS267,000,000 GBP (Excluding VAT), however this is approximate only and may vary depending on requirements of bodies purchasing under the Framework. Estimated total value over the 4 year agreement is approximately PS960,000,000 to PS1,067,000,000 Excluding VAT. Please note it is expected that the yearly spend for years 2 , 3 and 4 of the Framework Agreement will rise significantly. Following the National Institute for Health and Care Excellence (NICE) Technology Appraisal TA943 Overview | Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes | Guidance | NICE published 19th December 2023 and the NHS England Implementation Plan https://www.england.nhs.uk/long-read/hybrid-closed-loop-technologies-5-yearimplementationstrategy/

Lot Information

Insulin Pumps

This Lot aims to offer Patch Insulin Pumps and Tethered Insulin Pumps and associated consumables or accessories.

Continuous Glucose Monitors

This Lot aims to offer Continuous Glucose Monitors and associated consumables or accessories.

Software and Diabetes Management Systems

Applications and/or software that contributes to the functionality of a closed loop insulin delivery system. Products that connect with blood glucose sensors and insulin pumps to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with diabetes.

Insulin Pumps

This Lot aims to offer Patch Insulin Pumps and Tethered Insulin Pumps and associated consumables or accessories. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of PS140,000,000 to PS150,000,000 Excluding VAT in the first year. These are approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

Renewal: Option to extend up to a period of 48 Months

Continuous Glucose Monitors

This Lot aims to offer Continuous Glucose Monitors and associated consumables or accessories. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of PS75,000,000 to PS95,000,000 in the first year. These are approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. It is expected that the yearly spend for years 2 , 3 and 4 of the Framework Agreement will rise significantly.

Renewal: Option to extend up to a maximum of 48 months

Software and Diabetes Management Systems

Applications and/or software that contributes to the functionality of a closed loop insulin delivery system. Products that connect with blood glucose sensors and insulin pumps to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with diabetes. Additional information: Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of PS15,000 - PS17,000 in the first year. These are approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

Renewal: Option to extend for a maximum duration of 48 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04b4b0
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/079536-2025
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

48 - Software package and information systems

CPV Codes

33140000 - Medical consumables

33194000 - Devices and instruments for transfusion and infusion

33194110 - Infusion pumps

33194120 - Infusion supplies

48100000 - Industry specific software package

Notice Value(s)

Tender Value
£1,067,000,000 £1B-£10B
Lots Value
£1,067,000,000 £1B-£10B
Awards Value
Not specified
Contracts Value
£1,067,000,000 £1B-£10B

Notice Dates

Publication Date
3 Dec 20258 months ago
Submission Deadline
10 Mar 2025Expired
Future Notice Date
7 Jan 2025Expired
Award Date
5 Nov 20259 months ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Active, Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Supply Chain Coordination Ltd (SCCL)
Additional Buyers

NHS Supply Chain

NHS Supply Chain Operated by Supply Chain Coordination Ltd (SCCL)

Supply Chain Coordination Limited

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
Not specified
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
12
Supplier Names

Abbott Laboratories Limited

Advanced Therapeutics (UK) Ltd

Air Liquide Healthcare Ltd

Dexcom International Ltd

Glooko Limited

GlucoRx Ltd

Insulet International Ltd

Medtronic Limited

Medtrum Ltd

Novo Nordisk Limited

Urathon Europe Limited

Ypsomed Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...